Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful cells. The findings, recently published in Nature Communications, represent a major breakthrough in biomedical research. The researchers are now in the midst of testing the technology on human cancer cells as a potential cure for the disease but have not yet finished the study or published results.
This nanostructure technology, which was tested in human cell cultures, can be used as a molecular tool for biomedical research and therapeutics. Because it can be customized, it has the versatility to target multiple detrimental genes and proteins simultaneously.
The work was led by Professor Fei Zhang of the Rutgers-Newark Department of Chemistry and Professor Jean-Pierre Etchegaray of the Department of Biological Sciences at Rutgers-Newark, along with an interdisciplinary team of researchers.








